Cancer survivor (n = 19) | Potential interventionist (n = 7) | Stake-holder (n = 16) | Total (N = 42) | p value | ||
---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | N (%) | |||
Gender | Male | 0 (0) | 2 (28.6) | 4 (25.0) | 6 (14.3) | 0.03 |
Female | 19 (100.0) | 5 (71.4) | 12 (75.0) | 36 (85.7) | ||
Race | White | 15 (78.9) | 7 (100.0) | 15 (93.8) | 37 (88.1) | 0.37 |
Black | 4 (21.1) | 0 (0) | 1 (6.3) | 5 (11.9) | ||
Income | < $50,000 | 8 (42.1) | 1 (14.3) | 0 (0) | 9 (21.4) | 0.01 |
≥ $50,000 | 11 (57.9) | 6 (85.7) | 16 (100.0) | 33 (78.6) | ||
Married | Yes | 13 (68.4) | 6 (85.7) | 14 (87.5) | 33 (78.6) | 0.47 |
No | 6 (31.6) | 1 (14.3) | 2 (12.5) | 9 (21.4) | ||
Cancer typea | Breast | 9 (47.4) | – | – | 9 (47.4) | – |
Other | 10 (52.6) | – | – | 10 (52.6) | ||
Early cancer stagea | Yes | 11 (57.9) | – | – | 11 (57.9) | – |
No | 8 (42.1) | 8 (42.1) | ||||
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
Age, years | 61.8 (11.1) | 41.7 (15.2) | 45.9 (8.1) | 52.4 (13.7) | < 0.001b | |
Education, years | 15.1 (2.7) | 16.4 (0.8) | 17.3 (1.9) | 16.2 (1.4) | 0.019c | |
Years since diagnosisa,d | 2.8 (1.9) | – | – | 2.8 (1.9) | – | |
Miles from home to anticipated intervention site | 20.3 (17.9) | 27 (20) | 29.0 (11.5) | 24.7 (16.3) | 0.27 | |
CFIR domain | N (%)e | N (%) | N (%) | N (%) | ||
Innovation Characteristics | 36 (37.5) | 8 (25.0) | 32 (33.7) | 76 (34.1) | 0.57 | |
Outer Setting | 9 (9.4) | 4 (12.5) | 9 (9.5) | 22 (9.9) | ||
Inner Setting | 19 (19.8) | 10 (31.3) | 22 (23.2) | 51 (22.9) | ||
Characteristics of Individuals | 13 (13.5) | 1 (3.1) | 4 (4.2) | 18 (8.1) | ||
Process | 19 (19.8) | 9 (28.1) | 28 (29.5) | 56 (25.1) | ||
Total | 96 (100.0) | 32 (100.0) | 95 (100.0) | 223 (100.0) |